» Articles » PMID: 38751555

Preoperative Prediction of Microvascular Invasion with Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in Patients with Single Hepatocellular Carcinoma: The Implication of Surgical Decision on the Extent of Liver Resection

Overview
Journal Liver Cancer
Date 2024 May 16
PMID 38751555
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Microvascular invasion (MVI) is one of the most important prognostic factors for hepatocellular carcinoma (HCC) recurrence, but its application in preoperative clinical decisions is limited. This study aimed to identify preoperative predictive factors for MVI in HCC and further evaluate oncologic outcomes of different types and extents of hepatectomy according to stratified risk of MVI.

Methods: Patients with surgically resected single HCC (≤5 cm) who underwent preoperative gadoxetic acid-enhanced magnetic resonance imaging (MRI) were included in a single-center retrospective study. Two radiologists reviewed the images with no clinical, pathological, or prognostic information. Significant predictive factors for MVI were identified using logistic regression analysis against pathologic MVI and used to stratify patients. In the subgroup analysis, long-term outcomes of the stratified patients were analyzed using the Kaplan-Meier method with log-rank test and compared between anatomical and nonanatomical or major and minor resection.

Results: A total of 408 patients, 318 men and 90 women, with a mean age of 56.7 years were included. Elevated levels of tumor markers (alpha-fetoprotein [α-FP] ≥25 ng/mL and PIVKA-II ≥40 mAU/mL) and three MRI features (tumor size ≥3 cm, non-smooth tumor margin, and arterial peritumoral enhancement) were independent predictive factors for MVI. As the MVI risk increased from low (no predictive factor) and intermediate (1-2 factors) to high-risk (3-4 factors), recurrence-free and overall survival of each group significantly decreased ( = 0.001). In the high MVI risk group, 5-year cumulative recurrence rate was significantly lower in patients who underwent major compared to minor hepatectomy (26.6 vs. 59.8%, = 0.027).

Conclusion: Tumor markers and MRI features can predict the risk of MVI and prognosis after hepatectomy. Patients with high MVI risk had the worst prognosis among the three groups, and major hepatectomy improved long-term outcomes in these high-risk patients.

Citing Articles

Should lymphadenectomy be recommended in radical surgery of intrahepatic cholangiocarcinoma patients? A retrospective study.

Zhang R, Cao D, Yang M, Zhang J, Ye F, Huang N J Cancer Res Clin Oncol. 2025; 151(3):107.

PMID: 40072624 PMC: 11903595. DOI: 10.1007/s00432-025-06148-3.


MRI-Based Topology Deep Learning Model for Noninvasive Prediction of Microvascular Invasion and Assisting Prognostic Stratification in HCC.

Zheng T, Zhu Y, Jiang H, Yang C, Ye Y, Bashir M Liver Int. 2025; 45(3):e16205.

PMID: 39992060 PMC: 11849444. DOI: 10.1111/liv.16205.


MRI Features and Neutrophil-to-Lymphocyte Ratio (NLR)-Based Nomogram to Predict Prognosis of Microvascular Invasion-Negative Hepatocellular Carcinoma.

Wei Y, Huang X, Pei W, Zhao Y, Liao H J Hepatocell Carcinoma. 2025; 12:275-287.

PMID: 39974612 PMC: 11837745. DOI: 10.2147/JHC.S486955.


Evolving Indications for Liver Transplantation for Hepatocellular Carcinoma Following the Milan Criteria.

Kokudo T, Kokudo N Cancers (Basel). 2025; 17(3).

PMID: 39941874 PMC: 11815920. DOI: 10.3390/cancers17030507.


MRI-based prediction of microvascular invasion/high tumor grade and adjuvant therapy benefit for solitary HCC ≤ 5 cm: a multicenter cohort study.

Jiang H, Li B, Zheng T, Qin Y, Wu Y, Wu Z Eur Radiol. 2024; .

PMID: 39702639 DOI: 10.1007/s00330-024-11295-1.


References
1.
Moris D, Tsilimigras D, Kostakis I, Ntanasis-Stathopoulos I, Shah K, Felekouras E . Anatomic versus non-anatomic resection for hepatocellular carcinoma: A systematic review and meta-analysis. Eur J Surg Oncol. 2018; 44(7):927-938. DOI: 10.1016/j.ejso.2018.04.018. View

2.
Chernyak V, Fowler K, Kamaya A, Kielar A, Elsayes K, Bashir M . Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients. Radiology. 2018; 289(3):816-830. PMC: 6677371. DOI: 10.1148/radiol.2018181494. View

3.
Imai K, Yamashita Y, Yusa T, Nakao Y, Itoyama R, Nakagawa S . Microvascular Invasion in Small-sized Hepatocellular Carcinoma: Significance for Outcomes Following Hepatectomy and Radiofrequency Ablation. Anticancer Res. 2018; 38(2):1053-1060. DOI: 10.21873/anticanres.12322. View

4.
Bai S, Yang P, Xie Z, Li J, Lei Z, Xia Y . Preoperative Estimated Risk of Microvascular Invasion is Associated with Prognostic Differences Following Liver Resection Versus Radiofrequency Ablation for Early Hepatitis B Virus-Related Hepatocellular Carcinoma. Ann Surg Oncol. 2021; 28(13):8174-8185. DOI: 10.1245/s10434-021-09901-3. View

5.
Kawasaki Y, Yang S, Choi G, Han D, Lee J, Iino S . New scoring system for resectable hepatocellular carcinoma with a maximum tumor size of ≤5 cm based on preoperative tumor factors. HPB (Oxford). 2019; 21(10):1393-1399. DOI: 10.1016/j.hpb.2019.02.018. View